Drug Name and FDA Application Number | Dosage Form/Route | Strength | Marketing Status | Company |
SEREVENT
(NDA # 020236)
| AEROSOL, METERED; INHALATION |
EQ 0.021MG BASE/INH
|
Discontinued
| GLAXOSMITHKLINE |
SEREVENT
(NDA # 020692)
| POWDER; INHALATION |
EQ 0.046MG BASE/INH
|
Prescription
| GLAXO GRP LTD |